Skip to main content
Skip table of contents

Antibody Epitope Nomenclature

In order to ensure a consistent nomenclature for antibody targets we request that you use the following nomenclature:

  • epitope should be formatted using the following style:

    • if phospho-specific, have the prefix “phospho-” followed by

    • gene symbol/protein symbol e.g. “NF2” followed by

    • if phospho-specific, should label the phospho-target in parentheses with the three-character amino acid (aa) abbreviation followed by the location e.g. “(Ser2515)” followed by

    • if mutation-specific, should label the protein variant using one-character aa abbreviation eg. “(G12V)” followed by

    • if available, aa location of target in parentheses in the format of (aa START-END) e.g. “(aa 100-150)” or “(aa 507-530 N-term)”

    • examples of valid epitopes:

      • NF1

      • phospho-NF1 (Ser2515)

      • KRAS (G12V)

      • NF1 (aa 100-150)

      • NF1 (aa 507-530 N-term)

If you have an epitope that for does not fit in this nomenclature, let us know (Contact Us ) and we’d be happy to work with you to extend the nomenclature to fit your needs.

JavaScript errors detected

Please note, these errors can depend on your browser setup.

If this problem persists, please contact our support.